Suppr超能文献

MHC I 类分子在内吞体中的再循环:非专业抗原提呈细胞和树突状细胞。

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.

机构信息

Institut National de la Santé et de la Recherche Médicale, Unité 1151, Paris, France.

Université Paris Descartes, Faculté de Médecine, Paris, France.

出版信息

Front Immunol. 2019 Jan 7;9:3098. doi: 10.3389/fimmu.2018.03098. eCollection 2018.

Abstract

Major histocompatibility complex class I (MHC I) molecules are glycoproteins that display peptide epitopes at the cell surface of nucleated cells for recognition by CD8 T cells. Like other cell surface receptors, MHC class I molecules are continuously removed from the surface followed by intracellular degradation or recycling to the cell surface, in a process likely involving active quality control the mechanism of which remains unknown. The molecular players and pathways involved in internalization and recycling have previously been studied in model cell lines such as HeLa. However, dendritic cells (DCs), which rely on a specialized endocytic machinery that confers them the unique ability to "cross"-present antigens acquired by internalization, may use distinct MHC I recycling pathways and quality control mechanisms. By providing MHC I molecules cross-presenting antigens, these pathways may play an important role in one of the key functions of DCs, priming of T cell responses against pathogens and tumors. In this review, we will focus on endocytic recycling of MHC I molecules in various experimental conditions and cell types. We discuss the organization of the recycling pathway in model cell lines compared to DCs, highlighting the differences in the recycling rates and pathways of MHC I molecules between various cell types, and their putative functional consequences. Reviewing the literature, we find that conclusive evidence for significant recycling of MHC I molecules in primary DCs has yet to be demonstrated. We conclude that endocytic trafficking of MHC class I in DCs remains poorly understood and should be further studied because of its likely role in antigen cross-presentation.

摘要

主要组织相容性复合体 I 类 (MHC I) 分子是糖蛋白,可在有核细胞的细胞表面展示肽表位,供 CD8 T 细胞识别。与其他细胞表面受体一样,MHC I 类分子不断从表面被去除,随后被细胞内降解或再循环到细胞表面,这一过程可能涉及主动质量控制,但机制尚不清楚。内吞作用和再循环所涉及的分子参与者和途径以前曾在 HeLa 等模型细胞系中进行过研究。然而,树突状细胞 (DC) 依赖于专门的内吞机制,使它们具有“交叉”呈递通过内吞作用获得的抗原的独特能力,可能使用不同的 MHC I 再循环途径和质量控制机制。通过提供 MHC I 分子交叉呈递抗原,这些途径可能在 DC 的关键功能之一中发挥重要作用,即针对病原体和肿瘤的 T 细胞反应的启动。在这篇综述中,我们将重点讨论各种实验条件和细胞类型中 MHC I 分子的内吞再循环。我们讨论了模型细胞系与 DC 中再循环途径的组织,突出了各种细胞类型之间 MHC I 分子再循环率和途径的差异,及其潜在的功能后果。回顾文献,我们发现还没有确凿的证据表明主要 DC 中有大量 MHC I 分子再循环。我们得出结论,由于其在抗原交叉呈递中的可能作用,DC 中 MHC 类 I 的内吞转运仍知之甚少,应进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e896/6330327/9a4ef46aa84c/fimmu-09-03098-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验